Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-06-09 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1371 characters) and begins with 'RNS Number : 4344P', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational notice rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general regulatory fallback category.
2020-06-09 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1354 characters) and is explicitly labeled as an 'RNS Number'. The content describes a 'Price Monitoring Extension' for a security on the London Stock Exchange, which is a routine operational announcement related to trading mechanisms. This type of general regulatory announcement that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS, as per the definitions and the 'MENU VS MEAL' rule suggesting short announcements default to RNS/RPA if they aren't the primary report.
2020-06-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1371 characters) and originates from 'RNS, the news service of the London Stock Exchange'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory event notification. It does not contain detailed financial results (ER, IR, 10-K) or management/governance details. Since it is a general regulatory announcement provided via the RNS service that doesn't fit into the more specific categories like DIRS, DIV, or DLST, the most appropriate fallback category is Regulatory Filings (RNS).
2020-06-09 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1354 characters) and begins with 'RNS Number : 4124P', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a procedural update related to trading mechanisms, not a core financial report (like 10-K, ER, or IR). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate classification is the general regulatory filing fallback category.
2020-06-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly contains the header "RNS Number : 4149O" and mentions that the information is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content is a "TR-1: Standard form for notification of major holdings," which details changes in voting rights and share ownership thresholds (e.g., 3.76% vs 4.83%). This type of mandatory disclosure regarding significant changes in shareholding directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is about a major holding change, making MRQ the most precise classification over the general RNS fallback.
2020-05-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 3986O' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. This format, along with the content detailing changes in voting rights percentages (e.g., 4.40% direct, 1.50% financial instruments) by a shareholder (SPREADEX LTD), clearly identifies it as a regulatory filing concerning a change in major shareholding. This aligns directly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-05-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.